Literature DB >> 20401761

Kimura's disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up.

Enrico Beccastrini1, Giacomo Emmi, Michela Chiodi, Camilla Di Paolo, Elena Benedetta Silvestri, Daniela Massi, Enrico Maggi, Francesco Liotta, Lorenzo Emmi.   

Abstract

Kimura's disease is a benign chronic inflammatory disease, common in Asian males and rare in Western people. Clinically, Kimura's disease is characterized by subcutaneous nodular lesions, usually localised in head and neck, often associated with regional lymphadenopathy. Peripheral blood eosinophilia and elevated serum IgE are often observed. We report a case of a 40-year-old Italian patient presenting with nodular subcutaneous lesions and peripheral eosinophilia. Based on clinical, histopathological and laboratory findings, a diagnosis of Kimura's disease was made. The patient was treated with very low doses of cyclosporine A with no evidence of disease recurrence over the following 8 years. However, the discontinuation of cyclosporine A determined a relapse of the disease. The relevance of this case is due to the rarity of the disease in Italy, to its peculiar clinical presentation and, moreover, it is the first case in literature that has a good response to treatment with low doses of cyclosporine A, documented in an 8-year follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20401761     DOI: 10.1007/s10067-010-1449-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Kimura's disease with prolonged history and prominent vascular involvement.

Authors:  Mayumi Komine; Kunihiko Tamaki
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

Review 2.  Kimura's disease of the parotid region: report of 2 cases and review of the literature.

Authors:  Jean-Paul Meningaud; Poramate Pitak-Arnnop; Pierre Fouret; Jacques-Charles Bertrand
Journal:  J Oral Maxillofac Surg       Date:  2007-01       Impact factor: 1.895

3.  Kimura's disease in a Caucasian male treated with cyclosporine.

Authors:  Ahu Birol; Onder Bozdogan; Hatice Keleş; Mustafa Kazkayasi; Yeter Bagci; Simay Kara; Mukadder Koçak; Ahu Birol
Journal:  Int J Dermatol       Date:  2005-12       Impact factor: 2.736

4.  Ciclosporin improves quality of life in Kimura's disease.

Authors:  M Vourc'h; S Barbarot; J-F Stalder
Journal:  Br J Dermatol       Date:  2007-06-26       Impact factor: 9.302

5.  Kimura disease: diagnosis and prognostic factors.

Authors:  Hiroshi Iwai; Kaoru Nakae; Koshi Ikeda; Manabu Ogura; Makoto Miyamoto; Mariko Omae; Toshihiko Kaneko; Toshio Yamashita
Journal:  Otolaryngol Head Neck Surg       Date:  2007-08       Impact factor: 3.497

Review 6.  Kimura disease: review of the literature.

Authors:  Q-F Sun; D-Z Xu; S-H Pan; J-G Ding; Z-Q Xue; C-S Miao; G-J Cao; D-J Jin
Journal:  Intern Med J       Date:  2008-08       Impact factor: 2.048

7.  Combined treatment of steroids and cyclosporine in Kimura disease.

Authors:  Satoshi Sato; Hisashi Kawashima; Shinji Kuboshima; Kiyoko Watanabe; Yasuyo Kashiwagi; Kouji Takekuma; Akinori Hoshika
Journal:  Pediatrics       Date:  2006-08-14       Impact factor: 7.124

Review 8.  Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two disease entities in the same patient: case report and review of the literature.

Authors:  Wei-Sheng Chong; Anjula Thomas; Chee-Leok Goh
Journal:  Int J Dermatol       Date:  2006-02       Impact factor: 2.736

9.  Kimura's disease--an unusual cause of lymphadenopathy in children.

Authors:  Joe Thomas; Nambiar Veettil Jayachandran; Pradeep Kumar Shenoy Chandrasekhara; Liza Rajasekhar; Gumdal Narsimulu
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

10.  Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES.

Authors:  Y Kimura; R Pawankar; M Aoki; Y Niimi; S Kawana
Journal:  Clin Exp Allergy       Date:  2002-12       Impact factor: 5.018

  10 in total
  3 in total

Review 1.  Effective treatment of Kimura's disease with leflunomide in combination with glucocorticoids.

Authors:  Lie Dai; Xiu-Ning Wei; Dong-Hui Zheng; Ying-Qian Mo; Frank Pessler; Bai-Yu Zhang
Journal:  Clin Rheumatol       Date:  2011-02-01       Impact factor: 2.980

2.  Expression of the interleukin-21 and phosphorylated extracellular signal regulated kinase 1/2 in Kimura disease.

Authors:  Qing-Li Chen; Chen-Xi Li; Bo Shao; Zhong-Cheng Gong; Hui Liu; Bin Ling; Keremu Abasi; Lu-Lu Hu; Bing Wang; Xiao-Peng Yin
Journal:  J Clin Pathol       Date:  2017-01-20       Impact factor: 3.411

3.  Kimura's disease mimicking thoracic spine dumbbell neurogenic tumor: a case report and literature review.

Authors:  Siwei Bi; Jun Gu; Chenggong Hu
Journal:  BMC Surg       Date:  2020-09-21       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.